Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
79.74
-2.73 (-3.31%)
Feb 21, 2025, 4:00 PM EST - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $9.94 billion as of February 21, 2025. Its market cap has increased by 23.15% in one year.
Market Cap
9.94B
Enterprise Value
7.79B
1-Year Change
23.15%
Ranking
Category
Stock Price
$79.74
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $9.94B, an increase of 620.20%. That is a compound annual growth rate of 52.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 9.94B | -2.59% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |